These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A new mutant of bovine seminal ribonuclease with a reversed swapping propensity. Ercole C; Spadaccini R; Alfano C; Tancredi T; Picone D Biochemistry; 2007 Feb; 46(8):2227-32. PubMed ID: 17269658 [TBL] [Abstract][Full Text] [Related]
24. A role for the intersubunit disulfides of seminal RNase in the mechanism of its antitumor action. Bracale A; Castaldi F; Nitsch L; D'Alessio G Eur J Biochem; 2003 May; 270(9):1980-7. PubMed ID: 12709057 [TBL] [Abstract][Full Text] [Related]
25. Bovine seminal ribonuclease attached to nanoparticles made of polylactic acid kills leukemia and lymphoma cell lines in vitro. Michaelis M; Matousek J; Vogel JU; Slavik T; Langer K; Cinatl J; Kreuter J; Schwabe D; Cinatl J Anticancer Drugs; 2000 Jun; 11(5):369-76. PubMed ID: 10912953 [TBL] [Abstract][Full Text] [Related]
26. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin. Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482 [TBL] [Abstract][Full Text] [Related]
27. The multiple forms of bovine seminal ribonuclease: structure and stability of a C-terminal swapped dimer. Sica F; Pica A; Merlino A; Russo Krauss I; Ercole C; Picone D FEBS Lett; 2013 Nov; 587(23):3755-62. PubMed ID: 24140346 [TBL] [Abstract][Full Text] [Related]
28. Bovine seminal ribonuclease selectively kills human multidrug-resistant neuroblastoma cells via induction of apoptosis. Cinatl J; Cinatl J; Kotchetkov R; Vogel JU; Woodcock BG; Matousek J; Pouckova P; Kornhuber B Int J Oncol; 1999 Nov; 15(5):1001-9. PubMed ID: 10536185 [TBL] [Abstract][Full Text] [Related]
29. Bovine seminal ribonuclease induces in vitro concentration dependent apoptosis in stimulated human lymphocytes and cells from human tumor cell lines. Marinov I; Soucek J Neoplasma; 2000; 47(5):294-8. PubMed ID: 11130246 [TBL] [Abstract][Full Text] [Related]
30. Polymeric drug-carriers containing doxorubicin and melanocyte-stimulating hormone: in vitro and in vivo evaluation against murine melanoma. O'Hare KB; Duncan R; Strohalm J; Ulbrich K; Kopeckova P J Drug Target; 1993; 1(3):217-29. PubMed ID: 8069563 [TBL] [Abstract][Full Text] [Related]
31. Immunosuppressive activity of angiogenin in comparison with bovine seminal ribonuclease and pancreatic ribonuclease. Matousek J; Soucek J; Ríha J; Zankel TR; Benner SA Comp Biochem Physiol B Biochem Mol Biol; 1995 Oct; 112(2):235-41. PubMed ID: 7584854 [TBL] [Abstract][Full Text] [Related]
33. Gamma scintigraphy of the biodistribution of 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in mice with transplanted melanoma and mammary carcinoma. Pimm MV; Perkins AC; Strohalm J; Ulbrich K; Duncan R J Drug Target; 1996; 3(5):375-83. PubMed ID: 8866656 [TBL] [Abstract][Full Text] [Related]
34. Comparison between linear and star-like HPMA conjugated pirarubicin (THP) in pharmacokinetics and antitumor activity in tumor bearing mice. Nakamura H; Koziolová E; Etrych T; Chytil P; Fang J; Ulbrich K; Maeda H Eur J Pharm Biopharm; 2015 Feb; 90():90-6. PubMed ID: 25460144 [TBL] [Abstract][Full Text] [Related]
35. Immunosuppressive activity of bovine seminal ribonuclease and its mode of action. Soucek J; Marinov I; Benes J; Hilgert I; Matousek J; Raines RT Immunobiology; 1996 Aug; 195(3):271-85. PubMed ID: 8877402 [TBL] [Abstract][Full Text] [Related]
36. Antitumor activity and other biological actions of oligomers of ribonuclease A. Matousek J; Gotte G; Pouckova P; Soucek J; Slavik T; Vottariello F; Libonati M J Biol Chem; 2003 Jun; 278(26):23817-22. PubMed ID: 12697760 [TBL] [Abstract][Full Text] [Related]
37. Some biological actions of PEG-conjugated RNase A oligomers. Pouckova P; Skvor J; Gotte G; Vottariello F; Slavik JT; Matousek J; Laurents DV; Libonati M; Soucek J Neoplasma; 2006; 53(1):79-85. PubMed ID: 16416018 [TBL] [Abstract][Full Text] [Related]
38. A misfolded but active dimer of bovine seminal ribonuclease. Kim JS; Raines RT Eur J Biochem; 1994 Aug; 224(1):109-14. PubMed ID: 8076630 [TBL] [Abstract][Full Text] [Related]
39. Antitumor action of seminal ribonuclease, its dimeric structure, and its resistance to the cytosolic ribonuclease inhibitor. Antignani A; Naddeo M; Cubellis MV; Russo A; D'Alessio G Biochemistry; 2001 Mar; 40(12):3492-6. PubMed ID: 11297415 [TBL] [Abstract][Full Text] [Related]
40. Structure and stability of the non-covalent swapped dimer of bovine seminal ribonuclease: an enzyme tailored to evade ribonuclease protein inhibitor. Sica F; Di Fiore A; Merlino A; Mazzarella L J Biol Chem; 2004 Aug; 279(35):36753-60. PubMed ID: 15192098 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]